The Los Angeles Times | October 1, 2019
“You look at these enormous chunks crossed out, and think, ‘How could this possibly have seemed good for public health?’ ” said Eric Lindblom, a former official in the FDA’s Center for Tobacco Products, who now leads tobacco work at Georgetown Law’s O’Neill Institute.
“It’s as if they looked at each other and said, ‘If we’re not going to do anything about this problem, let’s delete anything that suggests we should.’ It’s a horror story,” he said.